Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PRGN-3007 |
Trade Name | |
Synonyms | PRGN3007|PRGN 3007|UltraCAR-T Cells PRGN-3007 |
Drug Descriptions |
PRGN-3007 are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting ROR1, membrane-bound IL-15, and kill switch genes, which potentially induce cytotoxicity against ROR1-expressing tumor cells and reduce tumor growth (Blood (2021) 138 (Supplement 1): 1694). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C192220 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PRGN-3007 | PRGN-3007 | 0 | 1 |